Erchonia FX 405 Cold Laser Therapy

Erchonia FX 405 Cold Laser Therapy

Erchonia FX 405 Cold Laser Therapy delivers parcels of light energy into the cell which the cell can use, and the parcels are delivered in the most effective and efficient way. This added energy fuels key processes, stimulating healing, relieving pain, reducing inflammation, and restoring function. The FX 405 Laser targets complex IV in the electron transport chain and also provides antimicrobial support, optimising ATP production and enhancing cellular health.

Treatment

Users remain awake throughout the entire laser treatment and experience no burning, scarring or downtime, allowing them to resume the rest of their day as soon as the session is over.

For Medical Professionals

Medical professionals have trusted Erchonia’s low-level lasers for treating various conditions for over 25 years and are increasingly turning to the valuable benefits of LLLT to manage a range of conditions more safely and effectively.

With the FX 405 medical staff can spend less time performing each treatment and use this valuable time to treat more patients and perform necessary tasks. Thanks to its triple-head, hands-free design, the medical professional just has to set up the FX 405 and go. This allows the physician to see other patients while the FX 405 does its work.

Are you ready to see just how easy and effective the low-level FX 405 laser is to implement into your practice? Contact us today.

Safe and effective treatment option for many conditions, including:

Arthritis
Carpal tunnel syndrome
Tendonitis
Bursitis
many more

FDA Approved for Your Health and Safety

The Erchonia FX 405, FDA approved study for chronic low back pain evaluated individuals suffering from chronic lower back pain for more than seven years. The study included two FX 405 laser visits weekly for four weeks. After eight FX405 laser treatments resulted in a 42% drop in chronic low back pain for participants in one month. After two months with no additional treatment, participants reported a 54% drop in their chronic low back pain. In a one-year follow-up evaluation participants in the study reported an almost 75% drop in their chronic low back pain.